Alpha-fetoprotein in plasma and serum of healthy adults: preanalytical, analytical and biological sources of variation and construction of age-dependent reference intervals

REFERENCES

• Christiansen M, Ishiguro T, Hogdall C, N orgaard-Pedersen B. Alpha-fetoprotein. In: Ballesta A, et al., editors. Updating on tumor markers in tissue and in biological fluids: basic aspects and clinical applications. Edizione Minerva Medica, Torino; 1993. p. 245–69.
   Google Scholar
• Norgaard-Pedersen B, Christiansen M, Jensen SP. a-fetoprotein in fetal pathology. In: Pasqualini JR, Scholler R, editors. Hormones and fetal patho-physiology. New York: Marcel Dekker, Inc; 1992. p. 369–412.
   Google Scholar
• Wu JT, Book L, Sudan K. Serum a-fetoprotein levels in normal infants. Pediatr Res 1981;15: 50–2.
   Google Scholar
• Chang YC, Nagasue N, Abe S, Taniura H, Kumar DD, Nakamura T. Comparison between the clinic-opathological features of AFP-positive and AFP-negative gastric cancers. Am J Gastroenterol 1992; 87: 321–5.
   PubMed Web of Science ®Google Scholar
• Kawamoto S, Hiraoke T, Kanemitsu K, Kimura H, Miyachi Y, Takeya M. Alpha-fetoprotein-producing pancreatic cancer-a case report and review of 28 cases. Hepatogastroenterology 1992; 39: 282–6.
   PubMedGoogle Scholar
• Taketa K. a-fetoprotein: re-evaluation in hepa-tology. Hepatology 1990; 12: 1420–32.
   PubMed Web of Science ®Google Scholar
• Ruoslahti E, Seppala M. a-foetoprotein in normal human serum. Nature 1972; 235: 161–2.
   PubMedGoogle Scholar
• Ruoslahti E, Seppala M. Studies of carcino-fetal proteins. III. Development of a radioimmunoassay for a-fetoprotein in serum of healthy human adults. Int J Cancer 1971; 8: 374–83.
   Google Scholar
• Purves LR, Purves M. Serum alpha-feto-protein. VI. The radio-immunoasay evidence for the pres-ence of AFP in the serum of normal people and during pregnancy. S Aft Med J 1972; 46: 1290–7.
   Google Scholar
• Purves LR, Branch WR, Geddes EW, Manso C, Portugal M. Serum alpha-feto-protein. VII. The range of apparent serum values in normal people, pregnant women, and primary liver cancer high risk populations. Cancer 1973; 31: 578–87.
   Google Scholar
• Chayvialle JAP, Ganguli PC. Radioimmunoassay of alpha-fetoprotein in human plasma. Lancet 1973; 1: 1355–7.
   PubMedGoogle Scholar
• Ball D, Rose E, Alpert E. Alpha-fetoprotein levels in normal adults. Am J Med Sci 1992; 303: 157–9.
   Google Scholar
• Masseyeff R, Gill J, Krebs B, Calluaud A, Bonet C. Evolution of alpha-fetoprotein serum levels throughout life in humans and rats, and during pregnancy in the rat. Ann NY Acad Sci 1975; 259: 17–28.
   Google Scholar
• Sizaret P, Tuyns AJ, Martel N. Alpha-fetoprotein levels in normal males from seven ethnic groups with different hepatocellular carcinoma risk. Ann NY Acad Sci 1975; 259: 136–55.
   Google Scholar
• Lehmann FG, Lehmann D. Vergleich verschied-ener methoden zum serologischen nachweis von al-fetoprotein im serum. Z Klin Chem Klin Biochem 1973;339–47.
   PubMedGoogle Scholar
• Bellet DH, Wands JR, Isselbacher KJ, Bohuon C. Serum alpha-fetoprotein levels in human disease: perspective from a highly specific monoclonal radioimmunoassay. Proc Natl Acad Sci USA 1984; 81: 3869–73.
   PubMed Web of Science ®Google Scholar
• Lester EP, Miller JB, Baron JM, Yachnin S. Inhibition of human lymphocyte transformation by human alpha-foetoprotein (HAFP): studies on the mode of HAFP action and the role of HAFP polymorphism. Immunology 1978; 34: 189–98.
   PubMedGoogle Scholar
• Cardoso E, Valdez G, Comini E, Matera L. Effect of human alpha-fetoprotein on native and in vitro stimulated NK activity. J Clin Lab Immunol 1991; 34: 183–8.
   PubMedGoogle Scholar
• Jacobson HI, Bennett JA, Mizejewski GJ. Inhibition of estrogen-dependent breast cancer growth by a reaction product of a-fetoprotein and estradiol. Cancer Res 1990; 50: 415–20.
   Google Scholar
• Keel BA, Eddy KB, Cho S, May JV. Human a-fetoprotein purified from amniotic fluid enhances growth factor mediated cell proliferation in vitro. Mol Reprod Devel 1991;30: 112–8.
   PubMedGoogle Scholar
• Lehmann FG. Prognostic significance of alphai-fetoprotein in liver cirrhosis: five-year prospective study. In: Fishmann WH, Sell S, editors. Onco-developmental gene expression. New York: Academic Press; 1976. p. 407–15.
   Google Scholar
• Mendenhall CL, Chedid A, French SW, Ray M, Roselle GA, Grossman CJ, et al. Alpha-fetoprotein alterations in alcoholics with liver disease. Alcohol Alcohol 1991; 26: 527–34.
   PubMedGoogle Scholar
• Chang YC, Nagasue N, Abe S, Taniura H, Kumar DD, Nakamura T. Comparison between the clinic-opathological features of AFP-positive and AFP-negative gastric cancers. Am J Gastroenterol 1992; 87: 321–5.
   PubMed Web of Science ®Google Scholar
• Christiansen M, Andersen JR, Toning J, Overgard 0, Jensen SP, Magid E, Norgaaard-Pedersen B. Serum alpha-fetoprotein and alcohol consumption. Scand J Clin Lab Invest 1994; 54: 215–20.
   Google Scholar
• Pollard DR, Gupta K. Stability of alpha-fetoprotein in stored and frozen-thawed aliquots. Clin Biochem 1982; 15: 266–7.
   PubMedGoogle Scholar
• Profilis C, Colinet E, Parfait RG, Terrana B. The production and certification of a highly purified human alpha-fetoprotein preparation as a reference material (CRM 486). BCR Information. European Commission Report EUR 16862 EN. 1996.
   Google Scholar
• Christiansen M, Yazova AK, Karamova ER, Andreev AV, Goussev Al, Mortensen V, et al. Epitopes of human alpha-fetoprotein: construction of an epitope-map from a large number of mono-clonal antibodies. J Tumor Marker Oncol 1994; 9: 57–68.
   Google Scholar
• Kricka U. Interferences in immunoassy-still a threat. Clin Chem 2000; 46: 1037–8.
   PubMed Web of Science ®Google Scholar
• Csako G, Weintraub BD, Zweig MH. The potency of immunoglobulin G fragments for inhibition of interference caused by anti-immunoglobulin anti-bodies in a monoclonal immunoradiometric assay for thyrotropin. Clin Chem 1988; 34: 1481–3.
   Google Scholar
• Altman DG. Practical statistics for medical research. 1st ed. London: Chapman & Hall; 1991. p. 1–611.
   Google Scholar
• Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clini-cal measurement. Lancet 1986; i: 307–10.
   Google Scholar
• Dybkwr R, Solberg HE. Approved recommen-dation (1987) on the theory of reference values. J Clin Chem Clin Biochem 1987; 25: 657–62.
   Google Scholar
• Solberg HE. Approved recommendation (1987) on the theory of reference values. Part 5. Statisti-cal treatment of collected reference values. Determination of reference limits. J Clin Chem Clin Biochem 1987; 25: 645–56.
   Google Scholar
• Anonymous. Equivalence between international units and mass units of alpha-foetoprotein. Report of a collaborative study. Clin Chim Acta 1979; 96: 59–65.
   Google Scholar
• Harris EK, Boyd JC. On dividing reference data into subgroups to produce separate reference ranges. Clin Chem 1990; 36: 265–70.
   PubMed Web of Science ®Google Scholar
• Reed AH, Henry RJ, Mason WB. Influence of statistical method used on the resulting estimate of normal range. Clin Chem 1971; 17: 275–84.
   Google Scholar
• Lott JA, Mitchell LC, Moeschberger ML, Sutherland DE. Estimation of reference ranges: How many subjects are needed? Clin Chem 1992; 38: 648–50.
   PubMedGoogle Scholar
• Kaczynski J, Jagenburg J, Lindstedt R, Wallerstedt S. Markedly increased alpha-fetoprotein concen-tration in serum in alcoholic liver disease: malig-nant tumor or non-neoplastic changes? Clin Chem 1992; 38: 710–6.
   PubMedGoogle Scholar
• Germa JR, Llanos M, Tabernero JM, Mora J. False elevations of alpha-fetoprotein associated with liver dysfunction in germ cell tumors. Cancer 1993;72: 2491–4.
   PubMedGoogle Scholar
• Hida S, Nishimura K, Nishio Y, Oishi K, Takeuchi H, Yoshida 0. VAB-6 chemotherapy causes spuri-ous elevation of alpha-fetoprotein associated with liver dysfunctions. Urol Int 1991;46: 1–5.
   Google Scholar
• Sarcione EJ, Biddle W. Elevated serum alpha-fetoprotein levels in postmenopausal women with primary breast carcinoma. Dis Markers 1987; 5: 76–9.
   Google Scholar
• Lichtenstein HS, Lyons DE, Wurfel MM, Johnson DA, McGinley MD, Leidii JC, et al. Afamin is a new member of the albumin, alpha-fetoprotein, and vitamin D-binding protein gene family. J Biol Chem 1994; 269: 18149–54.
   PubMedGoogle Scholar
• Ruoslahti E, Engvall E. Immunological cross-reaction between a-fetoprotein and albumin. Proc Natl Acad Sci USA 1976; 73: 4641–4.
   PubMedGoogle Scholar
• Pekkala-Flagan A, Ruoslahti E. Unfolded trans-ferrin polypeptide chain is immunologically cross-reactive with similar derivatives of serum albumin and a-fetoprotein. J Immunol 1982; 128: 1163–7.
   Google Scholar
• Karamova ER, Yazova AK, Goussev Al, Yakimenko EF, Abelev GI. Conformational vari-ants of human alpha-fetoprotein. Tumour Biol 1998; 19: 310–7.
   Google Scholar
• Forest JC, Verreault F, Pouliot M. Measurement of alpha-fetoprotein in maternal serum: three com-mercial radioimmunoassay kits and two non-commercial radioimmunoassays compared. Clin Chem 1982; 28: 339–43.
   Google Scholar
• Alpert E, Abelev GI. Summary report: epitope analysis of human alpha-fetoprotein. Tumour Biol 1998; 19: 290–2.
   PubMedGoogle Scholar